Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9030)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 18, 2017 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wani ZA, Mohapatra S, Khan AA, Mohapatra A, Yatoo GN. Addition of simvastatin to carvedilol non responders: A new pharmacological therapy for treatment of portal hypertension. World J Hepatol 2017; 9(5): 270-277 [PMID: 28261384 DOI: 10.4254/wjh.v9.i5.270] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i5/270.htm |
| Number | Citing Articles |
| 1 |
G Dispinzieri, C Becchetti, C Mazzarelli, A Airoldi, F Aprile, L Cesarini, M Cucco, G Perricone, R Stigliano, M Vangeli, R Viganò, LS Belli. Statin therapy: improving survival in patients with hepatocellular carcinoma and portal hypertension is possible?. Acta Gastro Enterologica Belgica 2024; 87(3): 395 doi: 10.51821/87.3.13018
|
| 2 |
Lauren R. Shaffer, Nadim Mahmud. Statins in Cirrhosis: Hope or Hype?. Journal of Clinical and Experimental Hepatology 2023; 13(6): 1032 doi: 10.1016/j.jceh.2023.05.002
|
| 3 |
Yue Gu, Xueqin Yang, Hang Liang, Deli Li. Comprehensive evaluation of effects and safety of statin on the progression of liver cirrhosis: a systematic review and meta-analysis. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1147-1
|
| 4 |
Alberto E Muñoz, Florencia D Pollarsky, Mónica Marino, Mariano Cartier, Horacio Vázquez, Pablo Salgado, Gustavo Romero. Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy. World Journal of Gastroenterology 2021; 27(28): 4639-4652 doi: 10.3748/wjg.v27.i28.4639
|
| 5 |
Jordi Gratacós-Ginès, Elisa Pose. Review of the role of statins in cirrhosis and portal hypertension. Clinical Liver Disease 2023; 22(2): 50 doi: 10.1097/CLD.0000000000000015
|
| 6 |
Sasan Sakiani, Theo Heller, Christopher Koh. Current and investigational drugs in early clinical development for portal hypertension. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.974182
|
| 7 |
Helinä Kahma, Marie-Noëlle Paludetto, Mikko Neuvonen, Mika Kurkela, Anne M. Filppula, Mikko Niemi, Janne T. Backman. Screening of 16 major drug glucuronides for time-dependent inhibition of nine drug-metabolizing CYP enzymes – detailed studies on CYP3A inhibitors. European Journal of Pharmaceutical Sciences 2024; 198: 106735 doi: 10.1016/j.ejps.2024.106735
|
| 8 |
Carlos Moctezuma-Velazquez, Juan Gonzalez Abraldes. The Role of Statins in Cirrhosis. Current Treatment Options in Gastroenterology 2022; 20(3): 316 doi: 10.1007/s11938-022-00394-x
|
| 9 |
Haifu Zhang, Qinxia Zhang, Shuojun Li, Biyun Xie. Simvastatin is Efficacious in Treating Cirrhosis. Journal of Clinical Gastroenterology 2022; 56(8): e303 doi: 10.1097/MCG.0000000000001732
|
| 10 |
Damien Leith, Rajeshwar P. Mookerjee. Evidence‐based Gastroenterology and Hepatology 4e. 2019; : 619 doi: 10.1002/9781119211419.ch41
|
| 11 |
Robert Schierwagen, Sabine Klein, Frank Uschner, Jonel Trebicka. Novel Targets and Drug Development in Portal Hypertension. Current Hepatology Reports 2019; 18(2): 187 doi: 10.1007/s11901-019-00462-4
|
| 12 |
Mohamad Kareem Marrache, Don C. Rockey. Statins for treatment of chronic liver disease. Current Opinion in Gastroenterology 2021; 37(3): 200 doi: 10.1097/MOG.0000000000000716
|
| 13 |
Shuen Sung, Mustafa Al-Karaghouli, Sylvia Kalainy, Lourdes Cabrera Garcia, Juan G. Abraldes. A systematic review on pharmacokinetics, cardiovascular outcomes and safety profiles of statins in cirrhosis. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01704-w
|
| 14 |
Alberto E. Muñoz, Mariano Cartier, Ayelén B. Kisch. Pharmacotherapy for Liver Cirrhosis and Its Complications. 2022; : 179 doi: 10.1007/978-981-19-2615-0_12
|
| 15 |
Muhammad Ali Butt, Rahul Karna, Shifa Umar, Abhishek Chaturvedi, Srinivas Murali, Tavankit Singh. Prescription patterns of statins in cirrhotic patients: a survey among primary care physicians and cardiologists. Baylor University Medical Center Proceedings 2024; 37(5): 769 doi: 10.1080/08998280.2024.2372753
|
| 16 |
Carlos Moctezuma-Velázquez, Juan G. Abraldes, Aldo J. Montano-Loza. The Use of Statins in Patients With Chronic Liver Disease and Cirrhosis. Current Treatment Options in Gastroenterology 2018; 16(2): 226 doi: 10.1007/s11938-018-0180-4
|
| 17 |
Sonia Selicean, Cong Wang, Sergi Guixé-Muntet, Horia Stefanescu, Norifumi Kawada, Jordi Gracia-Sancho. Regression of portal hypertension: underlying mechanisms and therapeutic strategies. Hepatology International 2021; 15(1): 36 doi: 10.1007/s12072-021-10135-4
|
| 18 |
Eric Felli, Yelidousi Nulan, Sonia Selicean, Cong Wang, Jordi Gracia-Sancho, Jaume Bosch. Emerging Therapeutic Targets for Portal Hypertension. Current Hepatology Reports 2023; 22(1): 51 doi: 10.1007/s11901-023-00598-4
|